Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
In the golden age of pharmaceutical nanocarriers, we are witnessing a maturation stage of the original concepts and ideas. There is no doubt that nanoformulations are extremely valuable tools for drug delivery applications; the current challenge is how to optimize them to ensure that they are safe,...
Main Authors: | Sebastián Scioli Montoto, Giuliana Muraca, María Esperanza Ruiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2020.587997/full |
Similar Items
-
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
by: Giuliana Muraca, et al.
Published: (2023-07-01) -
Influence of Surface-Modification via PEGylation or Chitosanization of Lipidic Nanocarriers on In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Apixaban
by: Mohamed F. Zaky, et al.
Published: (2023-06-01) -
Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation
by: Sebastian Scioli-Montoto, et al.
Published: (2022-08-01) -
Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
by: Li J, et al.
Published: (2018-07-01) -
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
by: Mohammed Elmowafy, et al.
Published: (2017-01-01)